Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

Ogawa Y, Okamoto S, Wakui M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125–1130.

Murphy PT, Sivakumaran M, Fahy G et al. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Bone Marrow Transplant 1996; 18: 641–642.

Ogawa Y, Okamoto S, Kuwana M et al. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroid. Cornea 2001; 20: 430–434.

Rocha EM, Pelegrino FS, de Paiva CS et al. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000; 25: 1101–1103.

Fox RI, Chan R, Michelson JB et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984; 27: 459–461.

Tsubota K, Goto E, Fujita H et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999; 83: 390–395.

Tananuvat N, Daniell M, Sullivan LJ et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001; 20: 802–806.

Tsubota K, Goto E, Shimmura S et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984–1989.

Goto E, Shimmura S, Shimazaki J et al. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001; 20: 807–810.

Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricialpemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996; 122: 38–52.

van Setten GB, Viinikka L, Tervo T et al. Epidermal growth factor is a constant component of normal human tear fluid. Graefe's Arch Clin Exp Ophthalmol 1989; 227: 184–187.

Poon AC, Geerling G, Dart JK et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001; 85: 1188–1197.

Tsubota K . The importance of the Schirmer test with nasal stimulation test. Am J Ophthalmol 1991; 111: 106–108.

Tsubota K, Toda I, Yagi Y et al. Three different types of dry eye syndrome. Cornea 1994; 13: 202–209.

Ohashi Y, Motokura M, Kinoshita Y et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci 1989; 30: 1879–1882.

Woost P, Jumblatt M, Eiferman R et al. Growth factors and corneal endothelial cells: II. Characterization of epidermal growth factor receptor from bovine corneal endothelial cells. Cornea 1992; 11: 11–19.

Lipps BV . Isolation of nerve growth factor (NGF) from human body fluids; saliva, serum and urine comparison between cobra venom and cobra serum NGF. J Nat Toxins 2000; 9: 349–356.

Kunert KS, Tisdale AS, Stern ME et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000; 118: 1489–1496.

Gordonson LC . Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol 2001; 132: 600–601.

Balaram M, Schaumberg DA, Dana MR . Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol 2001; 131: 30–36.

Pratt DV, Patrinely JR . Reversal of iatrogenic punctal and canalicular occlusion. Ophthalmology 1996; 103: 1493–1497.

Ogawa Y, Yamazaki K, Kuwana M et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42: 111–119.